Has Subha Varahan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,776 in general payments to Subha Varahan, MD across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Subha Varahan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Subha Varahan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Subha Varahan, MD

Clinical Cardiac Electrophysiology · Oklahoma City, OKNPI 1730380965

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 43.0% of the total. Reporting peaked in 2022 at $2,956 and has fallen 55.9% since, to $1,303 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OK, where the typical reported total is $22,745.

$9,776in general payments, 2019–2025

Across 157 payments — averaging $62.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$4K
Boston Scientific$2K
Biosense Webster, Inc.$1K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$758
Medical Device Business Services, Inc.$695
Abbott$511
plus $461 from 4 others

$1,697in research payments, 2019–2025

Across 5 payments — averaging $339.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$2K

What the payments were for

Consulting fees$2753%
Travel & lodging$3,91440%
Food & beverage$5,58757%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	52	$4,203
Boston Scientific	21	$1,857
Biosense Webster, Inc.	23	$1,292
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	43	$758
Medical Device Business Services, Inc.	3	$695
Abbott	4	$511
Philips North America LLC	3	$186
Impulse Dynamics (USA) Inc.	1	$136
Kestra Medical Technology Services, Inc.	4	$85
Irhythm Technologies, Inc.	3	$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,776 in reported general payments places this provider in the 15th percentile of 30 clinical cardiac electrophysiology providers in Oklahoma.

See all clinical cardiac electrophysiology providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$368,743

Medicare patients

1,106

Services billed

5,358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	646	$601,829
XareltoRivaroxaban	114	$101,786
Dofetilide	344	$53,907
Flecainide Acetate	264	$5,557
Metoprolol Succinate	430	$5,535
Dabigatran EtexilateDabigatran Etexilate Mesylate	22	$3,387
Amiodarone Hcl	247	$3,237
SotalolSotalol Hcl	145	$2,531
PradaxaDabigatran Etexilate Mesylate	12	$2,232
Diltiazem 24hr Er (Cd)Diltiazem Hcl	58	$1,839
Verapamil SrVerapamil Hcl	12	$1,817
Metoprolol Tartrate	133	$950
ClopidogrelClopidogrel Bisulfate	49	$820
Warfarin Sodium	61	$744
Levothyroxine Sodium	68	$613

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Oklahoma City

Warren JackmanOklahoma City$2.3M
Sunny PoOklahoma City$260K
John SummersOklahoma City$135K
Sean HalleranOklahoma City$105K
Ian ParkerOklahoma City$74K
Paul GarabelliOklahoma City$33K
Coty JewellOklahoma City$24K
Krittapoom AkrawinthawongOklahoma City$24K
Charles TeOklahoma City$21K
Terrance KhastgirOklahoma City$19K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →